Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas
about
Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and consGlycemic control indicators in patients with neonatal diabetes mellitus.Monogenic diabetes: Implementation of translational genomic research towards precision medicine.Neonatal Diabetes and the KATP Channel: From Mutation to Therapy.Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan.ADHD, learning difficulties and sleep disturbances associated with KCNJ11-related neonatal diabetes.Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controlsA Novel Approach to the Management of Neonatal Diabetes Using Sensor-Augmented Insulin Pump Therapy With Threshold Suspend Technology at Diagnosis.Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures.Neuropsychological impairments in children with KCNJ11 neonatal diabetes.Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.Congenital forms of diabetes: the beta-cell and beyond.Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
P2860
Q34628384-5671910E-04CD-4A37-94F3-904EF49BE0D4Q37708623-EDFADD3A-E317-4A32-A0DC-19D07EA51F7BQ38844084-51B4CB0F-A922-4883-87E3-E170B1CA8344Q39163344-0D853211-737F-45F7-A387-A3AF1B914A06Q39342397-CBB86C43-F13A-4D92-BD85-E2EF66A4690DQ39459508-07D71D3B-DBC2-4DDC-8D0D-D1860178DC31Q39737263-6D89EF29-D7A3-4959-BDCA-B038276AA9D5Q40955369-534D734B-4E9A-483A-B587-56665939A62EQ47200528-D0F8A4B6-F245-42A7-8FB1-BAE3DFD380F1Q48182415-56269413-B757-4C6D-A7E9-3FF513B1AB68Q48268391-AC5DF45B-4463-4AE0-AA95-1E5BB336F9A9Q49901335-16DF1FD6-88AA-440E-80D6-3C7803B1CB95Q50186120-FCD2CEBC-5D86-4995-9D15-C9F55B83C409Q57093273-5EDDB37E-D516-4C3B-A263-C8C720E077DA
P2860
Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Visuomotor performance in KCNJ ...... y treatment with sulfonylureas
@ast
Visuomotor performance in KCNJ ...... y treatment with sulfonylureas
@en
type
label
Visuomotor performance in KCNJ ...... y treatment with sulfonylureas
@ast
Visuomotor performance in KCNJ ...... y treatment with sulfonylureas
@en
prefLabel
Visuomotor performance in KCNJ ...... y treatment with sulfonylureas
@ast
Visuomotor performance in KCNJ ...... y treatment with sulfonylureas
@en
P2093
P2860
P356
P1433
P1476
Visuomotor performance in KCNJ ...... y treatment with sulfonylureas
@en
P2093
Brigette C Kragie
Michael E Msall
Reshma P Shah
Siri Atma W Greeley
P2860
P304
P356
10.2337/DC11-2225
P407
P50
P577
2012-08-01T00:00:00Z